Luo CW - Search Results

1

G9a governs colon cancer stem cell phenotype and chemoradioresistance through PP2A-RPA axis-mediated DNA damage response.

Luo CW, Wang JY, Hung WC, Peng G, Tsai YL, Chang TM, Chai CY, Lin CH, Pan MR. Luo CW, et al. Radiother Oncol. 2017 Sep;124(3):395-402. doi: 10.1016/j.radonc.2017.03.002. Epub 2017 Mar 25. Radiother Oncol. 2017. PMID: 28351524

2

Absence of CD66a expression is associated with high microvessel density and high histologic grade in hepatocellular carcinoma.

Wu CC, Yang SF, Chen WT, Tsai HP, Luo CW, Chai CY, Yin HL. Wu CC, et al. Among authors: luo cw. Kaohsiung J Med Sci. 2016 Jun;32(6):306-12. doi: 10.1016/j.kjms.2016.05.007. Epub 2016 Jun 28. Kaohsiung J Med Sci. 2016. PMID: 27377843 Free article.

3

Hypoxia-inducible factor-1α, vascular endothelial growth factor, inducible nitric oxide synthase, and endothelin-1 expression correlates with angiogenesis in congenital heart disease.

Yin HL, Luo CW, Dai ZK, Shaw KP, Chai CY, Wu CC. Yin HL, et al. Among authors: luo cw. Kaohsiung J Med Sci. 2016 Jul;32(7):348-55. doi: 10.1016/j.kjms.2016.05.011. Epub 2016 Jun 25. Kaohsiung J Med Sci. 2016. PMID: 27450023 Free article.

4

The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer.

Pan MR, Hsu MC, Luo CW, Chen LT, Shan YS, Hung WC. Pan MR, et al. Among authors: luo cw. Oncotarget. 2016 Sep 20;7(38):61136-61151. doi: 10.18632/oncotarget.11256. Oncotarget. 2016. PMID: 27531902 Free PMC article.

5

β1 Integrin as a Prognostic and Predictive Marker in Triple-Negative Breast Cancer.

Yin HL, Wu CC, Lin CH, Chai CY, Hou MF, Chang SJ, Tsai HP, Hung WC, Pan MR, Luo CW. Yin HL, et al. Among authors: luo cw. Int J Mol Sci. 2016 Aug 31;17(9):1432. doi: 10.3390/ijms17091432. Int J Mol Sci. 2016. PMID: 27589736 Free PMC article.

6

CHD4 as a Potential Biomarker in Differentiating Between Cellular Schwannoma and Malignant Peripheral Nerve Sheath Tumor.

Wu CC, Pan MR, Wei YC, Lin CH, Yang SF, Tsai HP, Luo CW, Chai CY. Wu CC, et al. Among authors: luo cw. Appl Immunohistochem Mol Morphol. 2018 Nov/Dec;26(10):775-780. doi: 10.1097/PAI.0000000000000522. Appl Immunohistochem Mol Morphol. 2018. PMID: 28549031

7

The NuRD complex-mediated p21 suppression facilitates chemoresistance in BRCA-proficient breast cancer.

Hou MF, Luo CW, Chang TM, Hung WC, Chen TY, Tsai YL, Chai CY, Pan MR. Hou MF, et al. Among authors: luo cw. Exp Cell Res. 2017 Oct 15;359(2):458-465. doi: 10.1016/j.yexcr.2017.08.029. Epub 2017 Aug 24. Exp Cell Res. 2017. PMID: 28842166

8

CHD4-mediated loss of E-cadherin determines metastatic ability in triple-negative breast cancer cells.

Luo CW, Wu CC, Chang SJ, Chang TM, Chen TY, Chai CY, Chang CL, Hou MF, Pan MR. Luo CW, et al. Exp Cell Res. 2018 Feb 1;363(1):65-72. doi: 10.1016/j.yexcr.2017.12.032. Epub 2018 Jan 3. Exp Cell Res. 2018. PMID: 29305962

9

Cell Motility Facilitated by Mono(2-ethylhexyl) Phthalate via Activation of the AKT-β-Catenin-IL-8 Axis in Colorectal Cancer.

Luo CW, Hsiao IL, Wang JY, Wu CC, Hung WC, Lin YH, Chen TY, Hsu YC, Cheng TL, Pan MR. Luo CW, et al. J Agric Food Chem. 2018 Sep 19;66(37):9635-9644. doi: 10.1021/acs.jafc.8b03558. Epub 2018 Sep 6. J Agric Food Chem. 2018. PMID: 30188700

10

Preprogramming therapeutic response of PI3K/mTOR dual inhibitor via the regulation of EHMT2 and p27 in pancreatic cancer.

Tian YF, Wang HC, Luo CW, Hung WC, Lin YH, Chen TY, Li CF, Lin CY, Pan MR. Tian YF, et al. Among authors: luo cw. Am J Cancer Res. 2018 Sep 1;8(9):1812-1822. eCollection 2018. Am J Cancer Res. 2018. PMID: 30323973 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

224 results

Search Page

Filters